Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1998 1
2001 1
2002 1
2004 2
2005 2
2006 2
2007 1
2008 3
2009 2
2010 4
2012 2
2013 6
2014 3
2015 4
2016 3
2017 8
2018 4
2019 6
2020 7
2021 8
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial.
Eggermont AMM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C; EORTC Melanoma Group. Eggermont AMM, et al. Lancet Oncol. 2021 May;22(5):643-654. doi: 10.1016/S1470-2045(21)00065-6. Epub 2021 Apr 12. Lancet Oncol. 2021. PMID: 33857412 Clinical Trial.
Patients aged 18 years or older with complete resection of cutaneous melanoma metastatic to lymph node, classified as American Joint Committee on Cancer staging system, seventh edition (AJCC-7) stage IIIA (at least one lymph node metastasis >1 mm), IIIB, or IIIC (without in …
Patients aged 18 years or older with complete resection of cutaneous melanoma metastatic to lymph node, classified as American Joint Committ …
Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial.
Eggermont AMM, Blank CU, Mandala M, Long GV, Atkinson VG, Dalle S, Haydon AM, Meshcheryakov A, Khattak A, Carlino MS, Sandhu S, Larkin J, Puig S, Ascierto PA, Rutkowski P, Schadendorf D, Koornstra R, Hernandez-Aya L, Di Giacomo AM, van den Eertwegh AJM, Grob JJ, Gutzmer R, Jamal R, Lorigan PC, van Akkooi ACJ, Krepler C, Ibrahim N, Marreaud S, Kicinski M, Suciu S, Robert C. Eggermont AMM, et al. J Clin Oncol. 2020 Nov 20;38(33):3925-3936. doi: 10.1200/JCO.20.02110. Epub 2020 Sep 18. J Clin Oncol. 2020. PMID: 32946353 Free PMC article. Clinical Trial.
PATIENTS AND METHODS: A total of 1,019 patients with complete lymph node dissection of American Joint Committee on Cancer Staging Manual (seventh edition; AJCC-7), stage IIIA (at least one lymph node metastasis > 1 mm), IIIB, or IIIC (without in-transit metast …
PATIENTS AND METHODS: A total of 1,019 patients with complete lymph node dissection of American Joint Committee on Cancer Staging Manual (se …
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.
Eggermont AM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbé C, Ferraresi V, Smylie M, Weber JS, Maio M, Konto C, Hoos A, de Pril V, Gurunath RK, de Schaetzen G, Suciu S, Testori A. Eggermont AM, et al. Lancet Oncol. 2015 May;16(5):522-30. doi: 10.1016/S1470-2045(15)70122-1. Epub 2015 Mar 31. Lancet Oncol. 2015. PMID: 25840693 Clinical Trial.
METHODS: We did a double-blind, phase 3 trial in patients with stage III cutaneous melanoma (excluding lymph node metastasis 1 mm or in-transit metastasis) with adequate resection of lymph nodes (ie, the primary cutaneous melanoma must have been completely ex …
METHODS: We did a double-blind, phase 3 trial in patients with stage III cutaneous melanoma (excluding lymph node metastasis 1 mm or in …
Malignant Melanoma: Diagnostic and Management Update.
Knackstedt T, Knackstedt RW, Couto R, Gastman B. Knackstedt T, et al. Plast Reconstr Surg. 2018 Aug;142(2):202e-216e. doi: 10.1097/PRS.0000000000004571. Plast Reconstr Surg. 2018. PMID: 30045186 Review.
Recommend sentinel lymph node biopsy and appropriate surgical margins based on individualized patient needs. 4. Recognize the currently available treatments for in-transit metastasis and advanced melanoma. 5. Describe current and future therapies for melanoma …
Recommend sentinel lymph node biopsy and appropriate surgical margins based on individualized patient needs. 4. Recognize the currently avai …
Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
Kus KJB, Murad F, Smile TD, Chang M, Ashrafzadeh S, Zhou G, Ilori EO, Koyfman SA, Vidimos AT, Schmults CD, Ruiz ES. Kus KJB, et al. J Am Acad Dermatol. 2022 Apr;86(4):766-773. doi: 10.1016/j.jaad.2021.11.002. Epub 2021 Nov 11. J Am Acad Dermatol. 2022. PMID: 34774657
METHODS: In total, 10,707 cutaneous squamous cell carcinoma tumors from a 20-year, retrospective, multicenter cohort were stratified by the presence (LVI(+)) or absence (LVI(-)) of LVI. Outcomes (local recurrence, in-transit metastasis, nodal metastasis, dise …
METHODS: In total, 10,707 cutaneous squamous cell carcinoma tumors from a 20-year, retrospective, multicenter cohort were stratified by the …
Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis.
Smile TD, Xiong DX, Varra V, Winter IW, Beal BT, Gastman BR, Geiger JL, Adelstein DJ, Bergfeld WF, Piliang MP, Billings SD, Ko JS, Knackstedt TJ, Lucas JL, Poblete-Lopez CM, Meine JG, Vij A, Vidimos AT, Koyfman SA. Smile TD, et al. Anticancer Res. 2021 Jan;41(1):289-295. doi: 10.21873/anticanres.14775. Anticancer Res. 2021. PMID: 33419823
BACKGROUND/AIM: Satellitosis/in-transit metastasis (S-ITM) has prognostic value in melanoma and Merkel cell carcinoma, but is not incorporated into cutaneous squamous cell carcinoma (cSCC) staging. ...
BACKGROUND/AIM: Satellitosis/in-transit metastasis (S-ITM) has prognostic value in melanoma and Merkel cell carcinoma, …
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.
Marti-Marti I, Podlipnik S, Cañueto J, Ferrándiz-Pulido C, Deza G, Sanmartín O, Jaka A, Beà-Ardèbol S, Botella-Estrada R, Redondo P, Turrión-Merino L, Ruiz-Salas V, Masferrer E, Yébenes M, Sánchez-Schmidt JM, Gracia-Darder I, Altemir-Vidal A, Aguayo-Ortiz RS, Becerril S, Bodet-Castillo D, Leal L, Fuente MJ, Moreno-Arrones OM, Abril-Pérez C, Tomás-Velázquez A, Sandoval-Clavijo A, Toll A. Marti-Marti I, et al. J Am Acad Dermatol. 2023 Jul;89(1):119-127. doi: 10.1016/j.jaad.2023.02.048. Epub 2023 Mar 10. J Am Acad Dermatol. 2023. PMID: 36907554
BACKGROUND: Satellitosis or in-transit metastasis (S-ITM) has clinical outcomes comparable to node-positivity in cutaneous squamous cell carcinoma (cSCC). ...
BACKGROUND: Satellitosis or in-transit metastasis (S-ITM) has clinical outcomes comparable to node-positivity in cutane …
Locoregional management of in-transit metastasis in melanoma: an Ontario Health (Cancer Care Ontario) clinical practice guideline.
Wright FC, Kellett S, Hong NJL, Sun AY, Hanna TP, Nessim C, Giacomantonio CA, Temple-Oberle CF, Song X, Petrella TM. Wright FC, et al. Curr Oncol. 2020 Jun;27(3):e318-e325. doi: 10.3747/co.27.6523. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669939 Free PMC article.
OBJECTIVE: The purpose of this guideline is to provide guidance on appropriate management of satellite and in-transit metastasis (itm) from melanoma. METHODS: The guideline was developed by the Program in Evidence-Based Care (pebc) of Ontario Health (Cancer C …
OBJECTIVE: The purpose of this guideline is to provide guidance on appropriate management of satellite and in-transit metas …
71 results